A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant
CURRENT ONCOLOGY（2024）
Key words
allogeneic hematopoietic cell transplant,donor lymphocyte infusion,minimal measurable disease,multiple myeloma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined